The LC-BC CCPs formed have no more than 12 nodes and identified only seven genes (EDNRB, CDKN2A, VEGFD, FOS, GNG11, TGFBR2, and BIRC5) compromised in signaling pathways associated with the acquisition of tumor characteristics. This evidence concerns the gene CDKN2A and breast cancer.